Hospital
Florida Hospital Dade City INC
Florida Hospital Dade City INC was paid $5.50M by Medicaid between Jan 2018 and Dec 2024, across 118 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.
33Billing provider infoFLORIDA HOSPITAL DADE CITY INC
DADE CITY, FL 33525
DADE CITY, FL 33525
33aNPI1215444054assigned 01/02/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.50M
24GClaims191,128
24DCodes billed118
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#80 of 163
Median peer was paid$4.77M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,684 | $163K | |
| 2019 | 38,452 | $877K | |
| 2020 | 33,504 | $764K | |
| 2021 | 43,931 | $1.15M | |
| 2022 | 37,981 | $1.19M | |
| 2023 | 20,683 | $859K | |
| 2024incomplete | 9,893 | $494K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 17,966 | 16,139 | $1.51M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 11,972 | 10,378 | $873K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.9% | 5,370 | 4,516 | $323K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.6% | 5,427 | 4,596 | $308K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.6% | 3,093 | 2,807 | $252K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3.4% | 999 | 847 | $186K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.4% | 1,824 | 1,474 | $185K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3.1% | 1,687 | 1,460 | $173K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 1,091 | 950 | $163K |
| 01999 | 2.4% | 1,689 | 1,544 | $130K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.2% | 926 | 791 | $123K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.2% | 3,186 | 2,631 | $122K |
106 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 3,402 | $105K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 1,847 | $91K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 1,124 | $81K |
| 80053 | Comprehensive metabolic panel | 1.5% | 13,102 | $80K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 1,405 | $79K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 3,634 | $73K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.0% | 677 | $55K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 4,794 | $49K |
| 87420 | <1% | 891 | $42K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,082 | $41K |
| 81025 | <1% | 1,839 | $33K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 618 | $28K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,875 | $26K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,583 | $25K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 843 | $24K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,237 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 978 | $22K |
| 73610 | <1% | 473 | $22K | |
| 81003 | <1% | 3,688 | $20K | |
| 84484 | <1% | 4,848 | $19K | |
| G0378 | Hospital observation service, per hour | <1% | 2,554 | $18K |
| 82947 | <1% | 2,183 | $17K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,928 | $14K |
| 73630 | <1% | 409 | $14K | |
| 81001 | <1% | 3,608 | $13K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 90 | $12K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 173 | $11K |
| 73130 | <1% | 313 | $11K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,351 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,789 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,947 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 904 | $7K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,146 | $6K |
| 96376 | <1% | 1,088 | $6K | |
| 87186 | <1% | 410 | $4K | |
| 84702 | <1% | 416 | $4K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 136 | $4K |
| 86900 | <1% | 281 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,867 | $4K |
| 80061 | Lipid panel | <1% | 597 | $3K |
| 73562 | <1% | 136 | $3K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 76 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 34 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,701 | $2K |
| 84703 | <1% | 997 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 18 | $1K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 101 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 294 | $1K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 70 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,987 | $1K |
| 80050 | General health panel | <1% | 58 | $1K |
| 73030 | <1% | 36 | $1K | |
| 85610 | <1% | 1,452 | $996.68 | |
| 85730 | <1% | 1,224 | $982.73 | |
| 88342 | <1% | 193 | $927.29 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,286 | $926.48 |
| 87077 | <1% | 592 | $851.99 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 116 | $796.33 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 13 | $707.76 |
| 83735 | <1% | 2,230 | $645.32 | |
| 83690 | <1% | 3,349 | $642.30 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 282 | $575.57 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 440 | $539.94 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,284 | $518.35 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 524 | $461.71 |
| 76801 | <1% | 43 | $453.48 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 553 | $319.13 |
| 87040 | <1% | 2,395 | $233.46 | |
| J2704 | Injection, propofol, 10 mg | <1% | 241 | $228.93 |
| 83605 | <1% | 2,019 | $223.07 | |
| 73110 | <1% | 55 | $218.62 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 990 | $159.78 |
| 83880 | <1% | 901 | $138.23 | |
| 12002 | <1% | 14 | $127.26 | |
| 74022 | <1% | 25 | $124.44 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 942 | $112.20 |
| 80047 | <1% | 35 | $90.42 | |
| 85027 | <1% | 948 | $86.82 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 322 | $43.41 |
| 85379 | <1% | 201 | $42.48 | |
| 12001 | <1% | 12 | $24.52 | |
| 82550 | <1% | 87 | $14.47 | |
| 82607 | <1% | 42 | $12.22 | |
| 84439 | <1% | 30 | $7.68 | |
| 86901 | <1% | 282 | $7.39 | |
| 86850 | <1% | 133 | $4.29 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 956 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 59 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 66 | $0.00 |
| 82077 | 0% | 249 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 60 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 33 | $0.00 |
| 87430 | 0% | 36 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 17 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 18 | $0.00 |
| 85652 | 0% | 17 | $0.00 | |
| 88304 | 0% | 13 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 179 | $0.00 |
| 90715 | 0% | 22 | $0.00 | |
| 74018 | 0% | 39 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 15 | $0.00 |
| 80076 | 0% | 14 | $0.00 | |
| 87210 | 0% | 55 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 115 | $0.00 |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | 0% | 29 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCRUNK, DANIEL (CFO)
| Provider | Location | Paid |
|---|---|---|
| Florida Hospital Zephyrhills INC | Zephyrhills, FL | $9.95M |
| Tarpon Springs Hospital Foundation INC | Tarpon Springs, FL | $6.03M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.